NFκB-dependent increase of kynurenine pathway activity in human placenta: Inhibition by sulfasalazine

Placenta

Volumn 31, Issue 11, 2010, Pages 997-1002

  Dharane, P ^a   Manuelpillai, U ^a   Wallace, E ^a   Walker, D W ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Inflammation; Kynurenines; NF B; Placenta; Sulfasalazine

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 6; KYNURENINE; MESSENGER RNA; SALAZOSULFAPYRIDINE; TRYPTOPHAN 2,3 DIOXYGENASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CESAREAN SECTION; CULTURE MEDIUM; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INCUBATION TIME; INFLAMMATION; MALE; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL NUCLEUS; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERLEUKIN-1; INTERLEUKIN-6; KYNURENINE; LIPOPOLYSACCHARIDES; NF-KAPPA B; ORGAN CULTURE TECHNIQUES; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RNA, MESSENGER; SULFASALAZINE; TRYPTOPHAN; TRYPTOPHAN OXYGENASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78049234210     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2010.09.002     Document Type: Article

References (32)

1. P. Ligam, U. Manuelpillai, E.M. Wallace, and D.W. Walker Localization of indoleamine 2,3-dioxygenase and kynurenine hydroxylase in the human placenta and decidua: implications for the role of the kynurenine pathway in pregnancy Placenta 26 2004 498 504
2. U. Manuelpillai, T. Nicholls, E.M. Wallace, D.J. Phillips, G. Guillemin, and D.W. Walker Increased mRNA expression of kynurenine pathway enzymes in human placentae exposed to bacterial endotoxin Adv Exp Med Biol 527 2003 85 89
3. U. Manuelpillai, P. Ligam, G.A. Smythe, E.M. Wallace, J.J. Hirst, and D.W. Walker Identification of kynurenine pathway enzyme mRNAs and metabolites in human placenta: up-regulation by inflammatory stimuli and clinical infection Am J Obstet Gynecol 192 2005 280 288
4. D.H. Munn, M. Zhou, J.T. Attwood, I. Bondarev, S.J. Conway, and B. Marshall Prevention of allogeneic fetal rejection by tryptophan catabolism Science 281 1998 1191 1193
5. A. Mellor Indoleamine 2,3 dioxygenase and regulation of T cell immunity Biochem Biophys Res Commun 338 2005 20 24
6. J.G. Drenzek, E.E. Breburda, D.W. Burleigh, G.I. Bondarenko, R.L. Grendell, and T.G. Golos Expression of indolamine 2,3-dioxygenase in the rhesus monkey and common marmoset J Reprod Immunol 78 2008 125 133
7. T.W. Stone Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection Trends Pharmacol 72 2000 411 412
8. I.P. Lapin Effect of kynurenine and quinilinic acid on the action of convulsants in mice Pharmacol Biochem Behav 13 1981 17 20
9. M.N. Perkins, and T.W. Stone An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid Brain Res 247 1982 184 187
10. S. Okuda, N. Nishiyama, H. Saito, and H. Katsuki 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity J Neurochem 70 1998 299 307
11. M.C. Bosco, A. Rapisarda, S. Massazza, H.G. Melillo, H. Young, and L. Varesio The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1 alpha and -1 beta in macrophages J Immunol 164 2000 3283 3291
12. M. Lappas, M. Permezel, and G.E. Rice Regulation of phospholipase isozymes by nuclear factor-κB in human gestational tissues in vitro J Clin Endocrin Metabol 89 2004 2365 2372
13. S. Fujigaki, K. Takahashi, H. Fujigaki, M. Takemura, M. Seishimi, and K. Saito Up-regulation of indoleamine 2,3-dioxygenase by lipopolysaccharide is regulated through activation of p38 mitogen-activated protein kinase and nuclear factor-κB Int Congress Series 1304 2007 200 204
14. P.A. Baeuerle, and T. Henkel Function and activation of NF-kappa B in the immune system Ann Rev Immunol 12 1994 141 179
15. A.A. Beg, and A.S. Baldwin Jr. The I kappa B proteins: multifunction regulators of Rel/NF-kappa B transcription factors Genes Dev 7 1993 2064 2070
16. A.S. Baldwin Jr. The NF kappa B and I kappa B proteins: new discoveries and insights Ann Rev Immunol 14 1996 649 683
17. M. Lappas, M. Permezel, H.M. Georgiou, and G.E. Rice Nuclear factor kappa B regulation of pro-inflammatory cytokines in human gestational tissues in vitro Biol Reprod 67 2002 668 673
18. P.A. Baeuerle, and V.R. Baichwal NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules Adv Immunol 65 1997 111 137
19. C. Wahl, S. Liptay, G. Adler, and R.M. Schmid Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B J Clin Invest 101 1998 1163 1174
20. N. Reti, M. Lappas, B. Huppertz, C. Riley, M.E. Wlodek, and P. Henshke Effect of high oxygen on placental function in short-term explants cultures Cell Tissue Res 328 2007 607 616
21. Y. Kudo, C.A. Boyd, I.L. Sargent, and C.W. Redman Modulation of indoleamine 2,3-dioxygenase by interferon-gamma in human placental chorionic villi Mol Human Reprod 6 2000 369 374
22. Y. Kudo, C.A. Boyd, I. Spyropoulou, C.W. Redman, O. Takikawa, and T. Katsuki Indoleamine 2,3-dioxygenase: distribution and function in the human developing placenta J Reprod Immunol 61 2004 87 98
23. M.X. Du, W.D. Sotero-Esteva, and M.W. Taylor Analysis of transcription factors regulating induction of indoleamine 2,3-diaoxygenase by IFN-gamma J Interferon Cytokine Res 20 2000 133 142
24. K. Mori, S. Stone, L. Khaodhiar, L.E. Braverman, and W.J. DeVito Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNFα) in FRTL-5 cells J Cell Biochem 74 1999 211 219
25. S. Fujigaki, K. Saito, K. Sekikawa, S. Tone, O. Takikawa, and H. Fujii Lipopolysaccharide induction of indoelamine 2,3-dioxygenase is mediated predominantly by an IFN-gamma-independent mechanism Eur J Immunol 31 2001 2313 2318
26. T.A. Babcock, and J.M. Carlin Transcriptional activation of indoleamine dioxygenase by interleukin-1 and tumor necrosis factor-alpha in interferon-treated epithelial cells Cytokine 12 2000 588 594
27. B. Hu, B.D. Hissong, and J.M. Carlin Interleukin-1 enhances indolamine 2,3-dioxygenase activity by increasing specific mRNA expression in human mononuclear phagocytes J Interferon Cytokine Res 15 1995 617 624
28. C. Mottet, P. Juillerat, J.J. Gonvers, F. Frohlich, B. Burnand, and J.P. Vader Pregnancy and Crohn's disease Digestion 71 2005 54 61
29. J. Doering, B. Begue, M.J. Lentze, F. Rieux-Laucat, O. Goulet, and J. Schmitz Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease Gut 53 2004 1632 1638
30. S. Zhao, Y. Gu, D.F. Lewis, and Y. Wang Predominant basal release of thromboxane, but not prostacyclin, by placental trophoblasts from normal and preeclamptic pregnancies Placenta 29 2008 81 88
31. B.R. Ryu, Y.A. Lee, S.J. Won, J.H. Noh, S.Y. Chang, and J.M. Chung The novel neuroprotective action of sulfasalazine through blockade of NMDA receptors J Pharmacol Exp Ther 305 2003 48 56
32. R. Schwarcz, W.O. Whetsell, and R.M. Mangano Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in the rat brain Science 219 1983 316 318